Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab

por Muñoz-Villegas, Patricia, Sanchez-Rios, Alejandra, Quinonez-Alvarado, Mayra G, Olvera-Montaño, Oscar, Quintana-Hau, Juan D, Baiza-Duran, Leopoldo
Publicado 2021

Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model

por Olvera-Montaño, Oscar, Baiza-Duran, Leopoldo, Quintana-Hau, Juan D, Quiñonez-Alvarado, Mayra G, Zeng, Wen, Gong, Li, Muñoz-Villegas, Patricia
Publicado 2019